Document is current
Any future updates will be listed below
-
Authors
Okawa, Tokutaro https://orcid.org/0000-0003-3664-4265
Okawa, Motomi https://orcid.org/0000-0002-6820-6860
Koike, Tatsuya https://orcid.org/0000-0002-1522-8740
-
Funding
Funding for this research was provided by:
AbbVie
Astellas Pharma
Bristol-Myers Squibb
Chugai Pharmaceutical
Daiichi-Sankyo
Eisai
Eli Lilly Japan
Mitsubishi Tanabe Pharma Corporation
MSD K.K.
Ono Pharmaceutical
Pfizer
Rochester Academy of Science
Takeda Pharmaceutical Company
Teijin Pharma
UCB US
- License Information
-
More Information
Article History
Received: 1 March 2022
Accepted: 5 July 2022
First Online: 8 August 2022
Declarations
:
: Dr. Koike has received grant fees, research fees, consulting fees, or other remuneration from AbbVie, Astellas Pharma Inc., Bristol-Myers Squibb, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Janssen, Lilly, Mitsubishi Tanabe Pharma Corporation, MSD, Ono Pharmaceutical, Pfizer, Roche, Takeda Pharmaceutical, Teijin Pharma, and UCB. None of the other authors have any conflicts of interest directly relevant to the content of this article.
